UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: September 5, 2024
Accession Number: 0001213900-24-074542
Submission Type: POS AM
CIK: 0001536196
Company Name: Can-Fite BioPharma Ltd.
File Number: 333-259085